Shire plc (LSE: SHP, NASDAQ: SHPG) announces that it plans to expand its global biotechnology manufacturing capacity over the next four years by investing US$400 million in Ireland to meet
Tag "Shire"
Drugmaker Shire agreed to acquire Baxalta International Inc after a six-month pursuit with $32bn cash and stock offer that will make it one of the world’s leading rare disease specialists.
Dublin-based drug maker Shire has made a new acquisition offer for peer Baxalta International that is roughly in line with the latter’s valuation expectations, according to people familiar with the
Advertisements
